Hibernating myocardium in heart failure

References

• Levy D, Kenchaiah S, Larson MG et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med.347, 1397–1402 (2002).
   PubMed Web of Science ®Google Scholar
• Mosterd A, Cost B, Hoes AW et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur. Heart J.2, 1318–1327 (2001).
   Google Scholar
• Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur. Heart J.23, 1867–1876 (2002).
   PubMed Web of Science ®Google Scholar
• Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation68, 785–795 (1983).
   PubMed Web of Science ®Google Scholar
• Rahimtoola SH. A perspective on the three large multicentre randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation72(Suppl. 5), 123–135 (1985).
   PubMed Web of Science ®Google Scholar
• Rahimtoola SH. The hibernating myocardium. Am. Heart J.117, 211–221 (1989).
   PubMed Web of Science ®Google Scholar
• Ross J. Myocardial perfusion–contraction matching. Implications for coronary heart disease and hibernation. Circulation83, 1076–1083 (1991).
   PubMed Web of Science ®Google Scholar
• Heyndrickx G, Millard R, McRitchie R, Maroko P, Vatner S. Regional myocardial function and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J. Clin. Invest.56, 978–985 (1975).
   PubMed Web of Science ®Google Scholar
• Braunwald E, Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation66, 1146–1149 (1982).
   PubMed Web of Science ®Google Scholar
• Bolli R. Myocardial “stunning” in man. Circulation86, 1671–1691 (1992).
   PubMed Web of Science ®Google Scholar
• Vanoverschelde JL, Wijns W, Depre C et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation87, 1513–1523 (1993).
   PubMed Web of Science ®Google Scholar
• Di Carli MF, Asgarzadie F, Schelbert HR et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation92, 3436–3444 (1995).
   PubMed Web of Science ®Google Scholar
• Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol.39, 1151–1158 (2002).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Visser FC, Poldermans D et al. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J. Nucl. Med.42, 87–90 (2001).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Poldermans D, Elhendy A et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J. Am. Coll. Cardiol.34, 163–169 (1999).
   PubMed Web of Science ®Google Scholar
• Schwaiger M, Schelbert H, Ellison D et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J. Am. Coll. Cardiol.6, 336–347 (1985).
   PubMed Web of Science ®Google Scholar
• Buxton D, Schelbert H. Measurement of regional glucose metabolic rates in reperfused myocardium. Am. J. Physiol.261, H2058–H2068 (1991).
   Google Scholar
• Arai AE, Pantely GA, Anselone CG, Bristow J, Bristow JD. Active down-regulation of myocardial energy requirements during prolonged moderate ischemia in swine. Circ. Res.69, 1458–1469 (1991).
   PubMed Web of Science ®Google Scholar
• McFalls E, Baldwin D, Palmer B, Marx D, Jaimes D, Ward H. Regional glucose uptake within hypoperfused swine myocardium as measured by PET. Am. J. Physiol.272, H343–H349 (1997).
   Google Scholar
• Fallavollita JA, Perry BJ, Canty JM. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation95, 1900–1909 (1997).
   PubMed Web of Science ®Google Scholar
• Fallavollita JA, Canty JM. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion. Evidence for chronic stunning in pigs. Circulation99, 2798–2805 (1999).
   PubMed Web of Science ®Google Scholar
• Shivalkar B, Flameng W, Szilard M, Pislaru S, Borgers M, Vanhaecke J. Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J. Am. Coll. Cardiol.34, 2126–2136 (1999).
   PubMed Web of Science ®Google Scholar
• McFalls EO, Murad B, Liow JS et al. Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia. Am. J. Physiol.282, H205–H211 (2002).
   Google Scholar
• Kim SJ, Peppas A, Hong SK et al. Persistent stunning induces myocardial hibernation and protection: flow/function and metabolic mechanisms. Circ. Res.92, 1233–1239 (2003).
   PubMed Web of Science ®Google Scholar
• Maes A, Flameng W, Nuyts J et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation90, 735–745 (1994).
   PubMed Web of Science ®Google Scholar
• Schwarz ER, Schaper J, vom Dahl J et al. Myocyte degeneration and cell death in hibernating human myocardium. J. Am. Coll. Cardiol.27, 1577–1585 (1996).
   PubMed Web of Science ®Google Scholar
• Elsasser A, Schlepper M, Klovekorn WP et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation96, 2920–2931 (1997).
   PubMed Web of Science ®Google Scholar
• Wiggers H, Noreng M, Paulsen PK et al. Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans. J. Am. Coll. Cardiol.37, 100–108 (2001).
   PubMed Web of Science ®Google Scholar
• Ausma J, Thone F, Dispersyn GD et al. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia tolerant. Mol. Cell. Biochem.186, 159–168 (1998).
   PubMed Web of Science ®Google Scholar
• Elsasser A, Muller K-D, Skwara W, Bode C, Kubler W, Vogt AM. Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J. Am. Coll. Cardiol.39, 1189–1198 (2002).
   PubMed Web of Science ®Google Scholar
• Gunning MG, Kaprielian RR, Pepper J et al. The histology of viable and hibernating myocardium in relation to imaging characteristics. J. Am. Coll. Cardiol.39, 428–435 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas SA, Fallavollita JA, Suzuki G, Borgers M, Canty JM. Dissociation of regional adaptations and global myolysis in an accelerated swine model of chronic hibernating myocardium. Circ. Res.91, 970–977 (2002).
   PubMed Web of Science ®Google Scholar
• Elsasser A, Vogt AM, Nef H et al. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J. Am. Coll. Cardiol.43, 2191–2199 (2004).
   PubMed Web of Science ®Google Scholar
• Elsasser A, Decker E, Kostin S et al. A self-perpetuating vicious cycle of tissue damage in human hibernating myocardium. Mol. Cell. Biochem.213, 17–28 (2000).
   PubMed Web of Science ®Google Scholar
• Ausma J, Fust D, Thone F et al. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J. Mol. Cell. Cardiol.27, 1203–1212 (1995).
   PubMed Web of Science ®Google Scholar
• Ausma J, van Eys GJ, Broers JL et al. Nuclear lamin expression in chronic hibernating myocardium in man. J. Mol. Cell. Cardiol.28, 1297–1305 (1996).
   PubMed Web of Science ®Google Scholar
• Pantely GA, Malone SA, Rhen WS et al. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ. Res.67, 1481–1493 (1990).
   PubMed Web of Science ®Google Scholar
• Zhang J, Ishibashi Y, Zhang Y et al. Myocardial bioenergetics during acute hibernation. Am. J. Physiol.273, H1452–H1463 (1997).
   Google Scholar
• Canty JM, Fallavollita JA. Resting myocardial flow in hibernating myocardium: validating animal models of human pathophysiology. Am. J. Physiol.277(1 Pt 2), H417–H422 (1999).
   PubMed Web of Science ®Google Scholar
• Camici PG, Rimoldi OE. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res.57, 302–311 (2003).
   PubMed Web of Science ®Google Scholar
• Uren N, Melin J, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N. Engl. J. Med.330, 1782–1788 (1994).
   PubMed Web of Science ®Google Scholar
• Pagano D, Fath-Ordoubadi F, Beatt J, Townend JN, Bonser RS, Camici PG. Effects of coronary revascularization on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. Heart85, 208–212 (2001).
   PubMed Web of Science ®Google Scholar
• al Mohammad A, Mahy IR, Norton MY et al. Prevalence of hibernating myocardium in patients with severely impaired ischemic left ventricles. Heart80, 559–564 (1998).
   PubMed Web of Science ®Google Scholar
• Auerbach MA, Schoeder H, Hoh C et al. Prevalence of myocardial viability as detected by PET in patients with ischemic cardiomyopathy. Circulation99, 2921–2926 (1999).
   PubMed Web of Science ®Google Scholar
• Schinkel AF, Bax JJ, Sozzi FB et al. Prevalence of myocardial viability by SPECT in patients with chronic ischemic left ventricular dysfunction. Heart88, 125–130 (2002).
   PubMed Web of Science ®Google Scholar
• Cleland JGF, Pennell DG, Ray SG et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (Christmas trial): randomized, controlled trial. Lancet362, 14–21 (2003).
   PubMed Web of Science ®Google Scholar
• Poldermans D, Rambaldi R, Bax JJ et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur. Heart J.19, 1712–1718 (1998).
   PubMed Web of Science ®Google Scholar
• Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J. Am. Soc. Echocardiogr.2, 358–367 (1989).
   PubMed Web of Science ®Google Scholar
• Cigarroa CG, de Fillipini CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echo identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation88, 430–436 (1993).
   PubMed Web of Science ®Google Scholar
• La Canna G, Alfiere O, Giubbini R, Gargano M, Ferrari R, Visiolo O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J. Am. Coll. Cardiol.23, 617–626 (1994).
   PubMed Web of Science ®Google Scholar
• Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography and myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation91, 663–670 (1995).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr. Prob. Cardiol.26, 147–186 (2001).
   PubMed Web of Science ®Google Scholar
• Piscione F, Perrone-Filardi P, De Luca G et al. Low-dose dobutamine echocardiography for predicting functional recovery after coronary revascularization. Heart86, 679–686 (2001).
   PubMed Web of Science ®Google Scholar
• Yong Y, Wu D, Fernandes V et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am. J. Cardiol.89, 711–718 (2002).
   PubMed Web of Science ®Google Scholar
• Shimoni S, Frangogiannis NG, Aggeli CJ et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation107, 538–544 (2003).
   PubMed Web of Science ®Google Scholar
• Wagdy HM, Christian TF, Miller TD, Gibbons RJ. The value of 24-hr images after rest thallium injection. Nucl. Med. Commun.23, 629–637 (2002).
   PubMed Web of Science ®Google Scholar
• He ZX, Darcourt J, Guignier A et al. Nitrates improve detection of ischemic but viable myocardium by thallium reinjection SPECT. J. Nucl. Med.34, 1472–1477 (1993).
   PubMed Web of Science ®Google Scholar
• Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N. Engl. J. Med.323, 141–146 (1990).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation83, 26–37 (1991).
   PubMedGoogle Scholar
• Matsunari I, Fujino S, Taki J et al. Quantitative rest technetium-99m tetrafosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. J. Am. Coll. Cardiol.29, 1226–1233 (1997).
   PubMed Web of Science ®Google Scholar
• Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation98, 501–508 (1998).
   PubMedGoogle Scholar
• Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J. Am. Coll. Cardiol.24, 1282–1289 (1994).
   PubMed Web of Science ®Google Scholar
• Mabuci M, Kubo N, Moria K et al. Prediction of recovery after coronary artery bypass graft surgery using quantitative gated myocardial perfusion SPECT. Nucl. Med. Commun.24, 625–631 (2003).
   PubMed Web of Science ®Google Scholar
• Mabuchi M, Kubo N, Morita K et al. Value and limitation of myocardial FDG SPECT using ultra high energy collimators for assessing myocardial viability. Nucl. Med. Commun.23, 879–885 (2002).
   PubMed Web of Science ®Google Scholar
• Tillisch J, Brunken R, Marshall S et al. Reversibility of cardiac wall-motion abnormalities predicted by PET. N. Engl. J. Med.314, 884–848 (1986).
   PubMed Web of Science ®Google Scholar
• Tamaki N, Kawamoto M, Tadamura E et al. Prediction of reversible ischemia after revascularization: perfusion and metabolic studies with PET. Circulation91, 1697–1705 (1995).
   PubMed Web of Science ®Google Scholar
• Kitsiou AN, Bacharach SL, Bartlett ML et al. 13N-ammonia blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. J. Am. Coll. Cardiol.33, 678–686 (1999).
   PubMed Web of Science ®Google Scholar
• Pagano D, Bonser RS, Townwnd JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and PET in identifying hibernating myocardium in patients with postischemic failure. Heart79, 281–288 (1998).
   PubMed Web of Science ®Google Scholar
• Pagano D, Lewis ME, Townwnd JN, Davies P, Camici PG, Bonser RS. Coronary revascularization for postischemic heart failure: how myocardial viability affects survival. Heart82, 684–688 (1999).
   PubMed Web of Science ®Google Scholar
• Baer FM, Theissen P, Schneider CA et al. Dobutamine MRI predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J. Am. Coll. Cardiol.31, 1040–1048 (1998).
   PubMed Web of Science ®Google Scholar
• Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced MRI to identify reversible myocardial dysfunction. N. Engl. J. Med.343, 1445–1453 (2000).
   PubMed Web of Science ®Google Scholar
• Wu E, Judd RM, Vargus JD, Klocke FJ, Bonow R, Kim RJ. Visualization of presence, location and transmural extent of healed Q-wave and non Q-wave MI. Lancet357, 21–28 (2001).
   PubMed Web of Science ®Google Scholar
• Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart83, 456–461 (2000).
   PubMed Web of Science ®Google Scholar
• Wagner A, Mahrholdt H, Holly TA et al. Contrast-enhanced MRI and routine single-photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet361, 374–379 (2003).
   PubMed Web of Science ®Google Scholar
• Schinkel AF, Bax JJ, Domburg R et al. Dobutamine-induced contractile reserve in stunned, hibernating and scarred myocardium in patients with ischemic cardiomyopathy. J. Nucl. Med.4, 127–133 (2003).
   Google Scholar
• Bax JJ, Maddahi J, Poldermans D et al. Sequential 201Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J. Nucl. Med.43(6), 795–802 (2002).
   PubMed Web of Science ®Google Scholar
• Elefteriades J, Tolis G, Levi E, Mills L, Zaret B. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J. Am. Coll. Cardiol.22, 1411–1417 (1993).
   PubMed Web of Science ®Google Scholar
• Vanoverschelde JL, Depre C, Gerber BL et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am. J. Cardiol.85, 1432–1439 (2000).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Visser FC, Poldermans D et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation104(Suppl. 1), I314–I318 (2001).
   PubMed Web of Science ®Google Scholar
• Di Carli F, Hachamovitch R, Berman DS. The art and science of predicting postrevascularization improvement in left ventricular function in patients with severely depressed left ventricular function. J. Am. Coll. Cardiol.40, 1744–1747 (2002).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Schinkel AFL, Boersma E et al. Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome. Circulation108(Suppl. 2), 39–42 (2003).
   Google Scholar
• Dalle Mule J, Bax JJ, Zingone B et al. The beneficial effect of revascularization on jeopardised myocardium: reverse remodeling and improved long-term prognosis. Eur. J. Cardiothorac. Surg.22, 426–430 (2002).
   PubMed Web of Science ®Google Scholar
• Di Carli MF, Maddahi J, Rokfsav S et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J. Thorac. Cardiovasc. Surg.116, 997–1004 (1998).
   PubMed Web of Science ®Google Scholar
• Canty JM, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA. Hibernating myocardium; chronically adapted to ischemia but vulnerable to sudden death. Circ. Res.94, 1142–1149 (2004).
   PubMed Web of Science ®Google Scholar
• Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. J. Am. Med. Assoc.273, 1450–1456 (1995).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Colucci WS, Swedberg K. β-blockers in chronic heart failure. Circulation107, 1570–1575 (2003).
   PubMed Web of Science ®Google Scholar
• Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity in patients with severe heart failure. N. Engl. J. Med.341, 709–717 (1999).
   PubMed Web of Science ®Google Scholar
• Pitt B, Remme W, Zannad F et al. Epleronone, a selective aldosterone blocker in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med.348, 1309–1321 (2003).
   PubMed Web of Science ®Google Scholar
• Bonow R. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J. Am. Coll. Cardiol.39, 1159–62 (2002).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Freemantle N, Ball SG et al. The HEArt failure Revascularization Trial (HEART): rationale, design and methodology. Eur. J. Heart Failure5, 295–303 (2003).
   PubMed Web of Science ®Google Scholar
• Granger CB, McMurray JJV, Yusus S et al. Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin-converting enzyme inhibitors: the CHARM-Alternative trial. Lancet362, 772–776 (2003).
   PubMed Web of Science ®Google Scholar